Bladder/Kidney/Other Urologic Cancers

AFINITOR (Everolimus) 5mg, 10mg tablets by Novartis

Afinitor Gains Indication for Non-cancerous Kidney Tumors

Novartis announced that the FDA has approved Afinitor (everolimus) tablets for the treatment of adults with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.